CD8A and neoplasm: In vivo, using the TAM-dominant murine MC38 cancer model, a dramatic reduction in tumor-infiltrating M2-like TAMs was observed, and other immune cell subpopulations were also affected by 3D185, including a decrease in FoxP3+ T regulatory cells and an increase in CD8+ T cells, especially activated CD8+ T cells.